Nishi, Kentaro
Sato, Mai
Ogura, Masao
Okutsu, Mika
Ishikura, Kenji
Kamei, Koichi http://orcid.org/0000-0003-3528-6961
Article History
Received: 20 March 2020
Accepted: 27 July 2020
First Online: 3 August 2020
Ethics approval and consent to participate
: Ethics approval was not applicable. Informed consent was obtained from all individual participants included in this report.
: Consent for publication was obtained from all individual guardians included in this report. Written informed consent was obtained from the legal guardians as participants were under 16 years old. This was for all potentially identifiable information contained within the manuscript file and that this is available for review by the editor of the journal.
: Koichi Kamei has received research funding from the Terumo Foundation for Life Sciences and Arts, and donations from Ono Pharmaceutical Co., Ltd. Kenji Ishikura has received lecture fees from Asahi Kasei Pharma, Chugai Pharmaceutical Co. Ltd., Zenyaku Kogyo Co., Ltd., Novartis Pharma K.K. and grants from Asahi Kasei Pharma, Chugai Pharmaceutical Co., Ltd., Novartis Pharma, and Zenyaku Kogyo Co., Ltd. The other authors have no potential conflicts of interest to disclose.